| For: | Bauer U, Gerum S, Roeder F, Münch S, Combs SE, Philipp AB, De Toni EN, Kirstein MM, Vogel A, Mogler C, Haller B, Neumann J, Braren RF, Makowski MR, Paprottka P, Guba M, Geisler F, Schmid RM, Umgelter A, Ehmer U. High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy. World J Gastroenterol 2021; 27(24): 3630-3642 [PMID: 34239274 DOI: 10.3748/wjg.v27.i24.3630] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i24/3630.htm |
| Number | Citing Articles |
| 1 |
Henry Sutanto, Galih Januar Adytia, Elisa Elisa, Ummi Maimunah. Advances in transarterial chemoembolization for hepatocellular carcinoma: Integration with systemic therapies and emerging treatment strategies. Cancer Pathogenesis and Therapy 2026; 4(1) doi: 10.1016/j.cpt.2025.04.004
|
| 2 |
Najib Ben Khaled, Thorsten Götze, Ursula Ehmer, Thomas Ettrich, Ilektra Antonia Mavroeidi, Christoph Roderburg, Dominik Paul Modest, Henning Wege, Peter Galle, Arndt Vogel, Lukas Perkhofer. Multimodale Therapieansätze beim hepatozellulären Karzinom – AIO-Studien im Fokus. Die Onkologie 2026; 32(5) doi: 10.1007/s00761-026-01951-0
|
| 3 |
Valentina Bianchi, Erida Nure, Carmen Nesci, Marco Maria Pascale, Gabriele Sganga, Salvatore Agnes, Giuseppe Brisinda. Bridge Therapy before Liver Transplant for Advanced Hepatocellular Carcinoma. Medicina 2024; 60(6) doi: 10.3390/medicina60061010
|
| 4 |
Laura Crocetti, Elena Bozzi, Paola Scalise, Irene Bargellini, Giulia Lorenzoni, Davide Ghinolfi, Daniela Campani, Emanuele Balzano, Paolo De Simone, Roberto Cioni. Locoregional Treatments for Bridging and Downstaging HCC to Liver Transplantation. Cancers 2021; 13(21) doi: 10.3390/cancers13215558
|
| 5 |
Hatem Adel, Muhammad K Shazlee, Saqib Qamar, Syed Muhammad Shahnawaz Hyder, Abdul Razaque. Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma. Cureus 2023; doi: 10.7759/cureus.41701
|
| 6 |
Aseel Y. Abualnil, Ritesh Kumar, Mridula A. George, Alexander Lalos, Mihir M. Shah, Matthew P. Deek, Salma K. Jabbour. Role of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2024; 33(1) doi: 10.1016/j.soc.2023.06.012
|
| 7 |
Nekisa Zakeri, Ramanivas Sundareyan, Owen Cain, James Good, Tahir Shah, Shishir Shetty. Stereotactic ablative radiotherapy for patients with hepatocellular carcinoma: analysis of post-treatment radiology and explant histology. BJC Reports 2025; 3(1) doi: 10.1038/s44276-025-00136-3
|
| 8 |
Mark P. Dumago, Ryan Anthony F. Agas, Carl Jay E. Jainar, Eugene T. Yap, Lester Bryan A. Co, Teresa T. Sy Ortin. Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Journal of Gastrointestinal Cancer 2023; 54(4) doi: 10.1007/s12029-023-00940-5
|
| 9 |
Muzamil Arshad, Connor Lynch, Rohan R. Katipally, Sean P. Pitroda, Ralph R. Weichselbaum. No disease left behind. Oncotarget 2025; 16(1) doi: 10.18632/oncotarget.28700
|